QIAGEN N.V. (QGEN) Dividend History

QIAGEN N.V. is a global provider of sample and assay technologies, serving the life sciences and molecular diagnostics markets. The company specializes in sample preparation, gene detection, and bioinformatics solutions designed for research, clinical, and molecular testing applications. QIAGEN's products facilitate the analysis of biological samples to detect, diagnose, and monitor diseases, making it a key player in advancing personalized healthcare and molecular diagnostics.

Website: https://www.qiagen.com

Company News

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment

The global molecular diagnostics for infectious disease market is poised for growth, driven by advancements in biotechnology and genomics, as well as the impact of multiplex assays on diagnosis and treatment. The report covers dynamic trends, including pathogen evolution, globalization, and climate change impacts, and provides insights on the U.S. Medicare Fee Schedules and global data.

GlobeNewswire Inc.

Featured Companies: A ABT BDX BIO BIO.B DHR HOLX QDEL TMO
Forensic Genomics Market Research 2025 - Global Trends, Opportunity, and Forecasts 2020-2030 - Growing Integration of Artificial Intelligence and Machine Learning

The forensic genomics market is expanding due to increased funding, heightened security concerns, and advanced forensic solutions demand. AI and machine learning enhance data analysis, improving investigative efficiency. However, data privacy and ethical concerns may hinder broader adoption.

GlobeNewswire Inc.

Featured Companies: A GEHC ILMN NEOG TMO
Cell-Free DNA Isolation and Extraction Market - Global and Regional Analysis 2025-2035 | Research and Clinical Labs Boost Adoption of Cell-Free DNA Technologies

The global cell-free DNA isolation and extraction market is growing due to rising cancer prevalence and government initiatives. Major players are investing in new products, leveraging techniques like PCR and NGS for applications in oncology and more.

GlobeNewswire Inc.

Featured Companies: A DHR ILMN PKI TMO
Europe Digital PCR Industry Research Report 2025: Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plans - Forecast to 2034

The European digital PCR market is expected to grow rapidly due to the increasing adoption of personalized medicine and the need for accurate diagnostics. Technological advancements, government initiatives, and growing research collaborations are driving the market's expansion.

GlobeNewswire Inc.
miRNA Sequencing and Assays Market Research Report 2025-2030 with Focus on 25+ Major Players Such as Abcam, HTG Molecular Diagnostics, Illumina, Lexogen, Meridian Bioscience

The miRNA Sequencing and Assays market is expected to grow from $379M in 2024 to $763.1M by 2030, driven by rising cancer prevalence, advancements in NGS technology, and growing demand for personalized medicine. Key players include Illumina and QIAGEN.

GlobeNewswire Inc.

Featured Companies: ILMN

Dividend data last updated 06/06/2025 20:47:25 UTC